SCHEMBL6204740

SCHEMBL6204740

COC([O])c1cccc(Cl)c1

nearest known ligand 0.50

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
AOC3 Q16853 1/20 0.50
ACP3 P15309 1/20 0.43
PDE1B Q01064 2/20 0.41
HSD17B2 P37059 1/20 0.41
SLC6A2 P23975 1/20 0.40
SLC6A4 P31645 1/20 0.40
SLC6A3 Q01959 1/20 0.40
CASR P41180 1/20 0.39
ALDH1A1 P00352 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6203322 0.79 AOC3 (0.53) AOC3ACP3PDE1BHSD17B2SLC6A2
SCHEMBL6205144 0.79 TSHR (0.38) AOC3ALDH1A1MEN1KMT2A
SCHEMBL11395224 0.78 AOC3 (0.51) AOC3ACP3PDE1BHSD17B2SLC6A2
SCHEMBL3096347 0.78 AOC3 (0.56) AOC3ACP3PDE1BHSD17B2SLC6A2
SCHEMBL6205041 0.78 IDO1 (0.46) ALDH1A1MEN1KMT2A
SCHEMBL5168017 0.78 AOC3 (0.49) AOC3ACP3ALDH1A1
SCHEMBL1047528 0.77 ACP3 (0.47) AOC3ACP3ALDH1A1MEN1KMT2A
SCHEMBL2601111 0.76 PNMT (0.47) AOC3ACP3PDE1BSLC6A2SLC6A4
SCHEMBL6204068 0.76 AOC3 (0.50) AOC3
SCHEMBL6202881 0.76 AOC3 (0.50) AOC3CASRALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1668601-A N-substituted tricyclic 3-aminopyrazoles as PDFG receptor inhibitors JANSSEN PHARMACEUTICA NV (BE) 2005-09-14 CN disclosed
EP-1506175-A1 N-SUBSTITUTED TRICYCLIC 3-AMINOPYRAZOLES AS PDGF RECEPTOR INHIBITORS JANSSEN PHARMACEUTICA N.V. (BE) 2005-02-16 EP disclosed
WO-2003097609-A1 N-SUBSTITUTED TRICYCLIC 3-AMINOPYRAZOLES AS PDFG RECEPTOR INHIBITORS JANSSEN PHARMACEUTICA N.V. (BE) 2003-11-27 WO disclosed